Disease | metabolic syndrome x |
Symptom | |diabetes |
Sentences | 161 |
PubMedID- 21892559 | Nonalcoholic fatty liver disease (nafld) is the most important cause of chronic liver disease and is considered the hepatic manifestation of the metabolic syndrome associated with diabetes mellitus type 2. |
PubMedID- 25699225 | diabetes is a group of metabolic syndromes and falls into two groups. |
PubMedID- 20197633 | Among the metabolic syndrome subjects, those with type 2 diabetes had significantly higher fasting blood glucose, systolic blood pressure and hs-crp values than those without diabetes. |
PubMedID- 23115071 | Introduction: at present, little data exists about the incidence of, and the risk factors associated with, metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm). |
PubMedID- 24595022 | We used the international diabetes federation's definition of metabolic syndrome . |
PubMedID- 22669833 | Relationship between serum testosterone levels and features of the metabolic syndrome defining criteria in patients with type 2 diabetes mellitus. |
PubMedID- 22370155 | The influence on the prevalence of metabolic syndrome was greater with the international diabetes federation (idf) criteria (19.3-23.9% in men and 29.4-43.1% in women) than with the adult treatment panel iii (atp iii) criteria (26.1-28.6% in men and 37.3-44.1% in women). |
PubMedID- 22486725 | Conclusions: inppl1 gene variants may contribute to susceptibility to the metabolic syndrome in men with type 1 diabetes, but not to diabetic nephropathy. |
PubMedID- 21409896 | The objective of the study was to observe the frequency of metabolic syndrome (mets) in patients with type 2 diabetes mellitus and study the relationship of insulin resistance with the metabolic syndrome and its different clinical parameters. |
PubMedID- 22231032 | Do albuminuria and hs-crp add to the international diabetes federation definition of the metabolic syndrome in predicting outcome. |
PubMedID- 23978069 | Hypertension, obesity, hyperlipidemia, and diabetes, the main manifestations of metabolic syndrome, do not always present simultaneously, while in obese patients, the presence of at least three of these manifestations can lead to crp elevation . |